New leadership role filled at ASHP to enhance pharmacy practice and public health

  • Samuel Calabrese appointed as Executive Vice President and CEO of ASHP
  • Experienced leader to enhance pharmacy practice and public health initiatives
  • Aim to strengthen ASHP's role in the healthcare industry

The American Society of Health-System Pharmacists (ASHP) has appointed Samuel Calabrese as its new Executive Vice President and Chief Executive Officer. Calabrese brings a wealth of experience in advancing pharmacy practice and public health initiatives, which are essential in today's healthcare landscape. His appointment is expected to strengthen ASHP's impact in advocating for pharmacy services within health systems nationwide.

Calabrese has a proven track record in leadership roles, previously holding important positions within the pharmacy community. His experience encompasses working with various healthcare organizations, developing strategic initiatives aimed at improving patient care. This new role will allow him to further contribute to the evolution of the pharmacy profession and to ASHP's mission of advancing health through pharmacy.

With Calabrese at the helm, ASHP aims to build upon its commitment to support pharmacists and enhance their roles in patient care. His leadership is poised to drive forward ASHP's initiatives, ensuring the organization remains a key player in shaping policies and practices that affect public health and pharmacy.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

Innovative automation enhances cancer research and immunological studies. AI-powered tools improve research…

Pharmacelera Raises $6M to Expand in US and Enhance Drug Discovery Platform

Funding will support growth and technological advancements in drug discovery. Pharmacelera has…

WuXi Biologics and Vertex Enter Research Agreement for T-Cell Engager

Collaboration focuses on advancing T-cell engager therapies for cancer treatment WuXi Biologics…

NUNM Receives $1.5 Million Gift to Support Campus Expansion and Future Integrative Medicine Center

Major donation aims to enhance educational opportunities at NUNM. NUNM receives a…